Methods: In this prospective trial, the amount of air leak was measured with the assistance of an anemometer connected to the top of a standard underwater drainage system, and a mobile phone with android operating system. Patients who underwent tube thoracostomy for spontaneous pneumothorax were assigned to group 1 (18 males, 1 female; mean age 31.6±10.9 years; range, 18 to 70 years), whereas patients who underwent lung resection for benign or malignant lung diseases were assigned to group 2 (37 males; 16 females; mean age 56.9±15.6 years; range, 18 to 80 years). The receiver operating characteristics analysis was performed for the statistical analysis of the data.
Results: Prolonged air leak was observed in five patients (26.3%) in group 1 and in six patients (11.3%) in group 2. In group 1, first measurement on postoperative day zero could detect prolonged air leak development with 100% sensitivity and 92.9% specificity. Similarly, in group 2, measurements on day zero could detect prolonged air leak development with 100% sensitivity and 87.2% specificity.
Conclusion: Compared to similar products, this newly developed measuring device may be widely used in clinics with its low cost and ease of use. Measured peak air leak flow values can predict patients who may develop prolonged air leak. Patent work for the device is ongoing.
In this study, we attempted to solve the aforementioned problems by using a simple anemometer. Anemometers were suited to UDS with a simple modification and the amount of air leak is measured quantitatively. In the second stage of study, we tried to predetermine patients who may develop prolonged air leak (PAL). Thus, we questioned the possibility of making the decision for surgery for patients admitted with primary spontaneous pneumothorax (SP), without waiting for the seven day period. Therefore, in this study, we aimed to evaluate a new method that detects peak air leak speed (PALS) and peak air leak flow (PALF), investigate the correlation between the amount of air leak and development of PAL, and identify patients who are at risk of developing PAL after lung resection.
Patients were divided into two groups: group 1 consisted of 19 patients (18 males, 1 female; mean age 31.6±10.9 years; range, 18 to 70 years) who underwent tube thoracostomy (TT) for SP. Following TT, all patients were evaluated with chest X-ray. Patients with traumatic or iatrogenic pneumothorax, and those with drain malposition were excluded. Patients with recurrent SP and those who underwent early surgery after TT (before seven days since the date of TT) were also excluded. Group 2 consisted of 53 patients (37 males; 16 females; mean age 56.9±15.6 years; range, 18 to 80 years) who underwent lung resection for benign or malignant lung diseases. Exclusion criteria for group 2 were as follows;
i. Patients who did not undergo parenchymal
lung resection (i.e. pleural-pericardial biopsy,
enucleation or only bronchial resection),
ii. Mesothelioma patients who underwent lung
resection, total decortication, and hyperthermic
chemotherapy within the same session,
iii. Patients who underwent pneumonectomy
(as their drains were monitored with clamps),
iv. Patients who underwent lung resection for
traumatic and resuscitative causes,
v. Patients who underwent revision surgery due
to postoperative bleeding,
vi. Patients without air leak after lung resection,
vii. Patients transferred to intensive care unit
(ICU) without extubation after surgery (as the
level of air leak could vary depending on the
settings of the mechanical ventilator).
The amount of drainage, time until drain removal, complications and treatments were recorded for each patient. All chest drains were removed during the deep inspiration phase. Patients who had air leak for seven days or over were accepted as ''PAL developed patients'' for all groups. Diagnosis of PAL was established by a surgeon blinded towards all PALF values.
All measurements were performed with a digital anemometer (WeatherFlow® Weathermeter, California, USA) (Figure 1). The device is capable of measuring the mean air flow rate and the maximum flow rate. Technical features of the device enable it to connect to mobile phones with android operating systems (Google Inc., Mountain View, California, USA) via Bluetooth (Bluetooth SIG, Inc., Headquarters, Kirkland, USA). The device has been calibrated by the University of Florida at Department of Aerospace Engineering. The device can measure air flow rate within a range of 0.4-55 m/sec with ±0.5% accuracy.
With simple modifications, the digital anemometer was fitted to the air discharge pipe of the drainage bottle (Figure 1). As a result, we created a system which is applicable to standard UDS and do not have any contact with the patient"s fluids. Results were monitored from the mobile phone and recorded in phone memory. In this way, the measurements were transferred to a digital information system.
Air flow speed measured by the anemometer was converted to flow rate by the following formula: Q=V ¥ A; where Q is flow rate (cm3/sec), V is velocity (cm/sec), and A is cross-sectional area (cm2). In summary, PALS values were measured first, and then corresponding PALF values were calculated with the formula.
In group 1, measurements were performed according to standardized measurement sessions, which follow strict regulations, and which were repeated twice daily. In each session, patients were asked to cough vigorously, take deep breaths, and count. During each respiratory maneuver (in each coughing, deep breathing and counting steps), two measurements were performed, and the arithmetic mean of these measurements was calculated to determine PALS. If any of the measurements was beyond the measurement range, a third measurement was performed, and the arithmetic mean of the two highest measurements was calculated. For each PALS value, the corresponding PALF value was calculated with the following formula: "Q=V ¥ A?. During the first measurement on day zero, the highest PALF value was considered as "PALF0".
Second measurements on day zero were performed as scheduled (same as the first measurement), and were recorded as PALF00. The highest PALF value between morning and evening measurements on postoperative day one was considered as "PALF1". The same procedure was performed on other days, and values were recorded as "PALF2" and "PALF3". In sum, two PALF values were determined for day zero, and only one PALF value was determined for other days. Measurements continued until air drainage from the thorax drain was stopped. If air leak continued for seven days or over, measurements were terminated. These patients were either treated with surgical treatment or UDS were replaced with Heimlich valve.
In group 2, the first measurements (PALS0) were performed after the patients were extubated and transferred to ICU, given standard analgesics, evaluated with lung graphy and sufficient wakefulness was detected. Similar to measurements in group 1, patients were asked to cough, take deep breaths and count. Measurements on patients with air leaks from both chest drains were performed from the apical drain, after clamping the basal drain. Afterwards, PALF0 value was calculated for each respiratory maneuver. Second measurements on postoperative day zero were performed approximately four hours after the first measurement. The highest PALF value in this measurement was recorded as PALF00. Subsequent measurements were performed during scheduled times in the morning (07:00-10:00) and evening (17:30-19.00). The highest measurement for each day was considered as the PALF value of the day.
Statistical analysis
Statistical analysis was performed using the IBM
SPSS version 21.0 software (IBM Corp., Armonk,
NY, USA). First, receiver operating characteristic
(ROC) curves were generated from PALF values (PALF0, PALF00, PALF1 etc.) in group 1 to calculate
cut-off values which would indicate PAL development.
Statistical significance, sensitivity and specificity
values were calculated for each cut-off value. The same
procedure was performed for postoperative PALF
values in group 2.
Prolonged air leak was observed in five of 19 patients (26.3%) in group 1. Three of these patients underwent videothoracoscopic wedge resection and patients were discharged without any complication. Histopathological examinations of surgical specimens showed signs of bullous emphysema in two patients, and Langerhans cell histiocytosis in one patient. Active tuberculosis was detected in one patient and one had advanced COPD. Therefore, these patients did not undergo surgery and were discharged with Heimlich valves.
Prolonged air leak was not observed in any of the 13 patients with a PALF0 value <212 mL/sec. Three patients had a PALF0 value between 212-500 mL/sec, and PAL development was observed in two patients. Three patients had a PALF0 value >500 mL/sec, and PAL development was observed in all of these patients. The PALF values on other days and their correlation with PAL were shown in Table 1.
Table 1: Summary of postoperative measurements in group 1
The ROC analysis was performed to determine the prognostic significance of measured PALF values and to calculate significant cut-off values. Receiver operating characteristic curves, putative cut-off values, sensitivity and specificity values based on the cut-off values were recorded (Figure 2).
Figure 2: Receiver operating characteristic graphs for group 1.
A PALF0 cut-off value of 265.24 mL/sec was able to predict PAL development with 100% sensitivity and 92.9% specificity. When the PALF00 cut-off value was set to 238.7 mL/sec, PAL development could be determined with 100% sensitivity and 92.9% specificity. The procedure was repeated for observed PALF values on other days (e.g. PALF2, PALF3) and the results were recorded. A decrease in the sensitivity and specificity values was detected on the third and the following days. This was due to the fact that patients whose air drainage stopped and thorax drains were removed were excluded from the statistical analysis, so total sample decreased. In particular, from day four, PAL development was observed in all patients with an air leak. Therefore, we were unable to get a statistically significant result for third and following days. For group 1, the cut-off values obtained from ROC analysis and calculated sensitivity and specificity values were summarized in Table 2.
In group 2, the mean ages of male and female patients were 56.8±16.2 years (range, 18 to 80 years) and 57.1±14.6 years (range, 23 to 72 years), respectively. Patients' demographic features, surgical treatments, and histopathological examination results were summarized in Table 3.
Table 3: Demographic features of patients in group 2
Prolonged air drainage was observed in six patients. Forty patients had a PALF0 value <212 mL/sec, and PAL was not observed in any of these patients. Eight patients had a PALF0 value between 212-500 mL/sec, and PAL was observed in only one patient. Five patients had a PALF value >500 mL/sec, and PAL was observed in all five patients. Other PALF values and their correlation with PAL were summarized in Table 4.
Table 4: Summary of postoperative measurements in group 2
Subsequently, the ROC analysis was performed for each PALF value. Similar to group 1, the PALF cut-off values and their sensitivity and specificity to predict PAL development were determined (Figure 3). Overall results for patients in group 2 were shown in Table 5.
Figure 3: Receiver operating characteristic graphs for group 2.
Table 5: Receiver operating characteristic analysis for peak air leak flow values in group 2
For the measurement of the PAF value as a prognostic factor, we were inspired by the peak expiratory flow meters (PEF-meter) that are used for evaluating treatment response in patients with asthma. It is known that PEF-meters can be used by asthma patients without requiring help, and they offer a cheap, effective, and easy measurement method. Peak expiratory flow meters measure the air flow during strong expiration.[18-20] H igh P EF v alues a re generally considered as an indicator of good response to treatment.[18,19] Similarly, the use of PALF values to predict PAL development is a logical approach. Air leaks are known to decline over time, and eventually cease. In case of patients with massive air leaks, it is reasonable to hypothesize that the air leak will decrease rather slowly and it will take a long time to cease. A second hypothesis is that air leaks with high flow rate may indicate large lung damage that will not end without an intervention. In our study, massive air leaks were directly clarified with increased PALF values. We obtained two PALF values for postoperative day zero, and one PALF value on the subsequent days. These quantitative data offered an opportunity for a statistical comparison, and a possibility to calculate a cut-off value. The ROC analyses for group 1 revealed that particularly PALF0, PALF00, and PALF1 values can determine PAL development with high specificity and sensitivity (>90%).
The results in group 2 were similar to group 1. The PALF0 cut-off value of 291.74 mL/sec could detect PAL development with 100% sensitivity and 87.2% specificity. The PALF00 could detect PAL development with 100% sensitivity and 84.8% specificity, whereas PALF1 could detect PAL development with 83% sensitivity and 77.8% specificity. The decreasing trend in sensitivity and specificity values are likely to result from the reduction in total number of patients, as patients were excluded from further analysis after removal of drains.
Based on the results of this study, we believe that measurements on patients with SP after TT on days zero, one, and two would enable early detection of PAL, and will guide the decisions for surgery. Based on the results in the first two days, the decision for surgery can be established without having to wait for a period of five to seven days. By using these results, it may be possible to prevent unnecessary hospitalization of patients during the preoperative period.
Detection of PAL during early postoperative period for patients in group 2 may ensure that interventions towards minimizing air leak can be performed relatively soon.
The digital drainage systems used to measure air leak, such as Thopaz (Medela AG, Lättichstrasse, Baar, Switzerland) or Airfix (TEUP"s Ltd., Deutschlandsberg, Austria), etc. have not been widely used in our country due to their high costs. They can be used only on one patient at a time, and each device requires use of special drainage bottles.[13] In this regard, both the device and the special drainage bottles that should be used increase the cost. In our study, we used a simple anemometer to measure air leakage. The changes made to the anemometers to ensure that they are compatible with the UDS did not result in any additional cost. All in all, the entire system costed 600 Turkish liras (US$125). Compared to other systems with similar functions (which cost around US$15,000), our system is clearly far more favorable in terms of its high benefit-to-cost ratio.
The major limitation of this study is related to the technical features of the anemometer. In some studies in the literature, different types of anemometers have been used for medical measurement, and results have been compared to flow-meters.[21] Compared to digital drainage systems, the anemometer used in our study has lower sensitivity. We attempted to overcome this technical limitation to a certain extent, by using PALS-PALF values instead of continuous measurements. Other limitations include the singlecenter nature of the study, and very small sample size. We attempted to overcome both limitations by obtaining sufficient numbers of measurements and using appropriate statistical methods.
In conclusion, this pioneering study provided a new and practical technique for quantitative measurement of air leaks, and described new and important prognostic parameters, such as peak air leak speed and peak air leak flow. Patent work for the device is ongoing.
Declaration of conflicting interests
The authors declared no conflicts of interest with respect to
the authorship and/or publication of this article.
Funding
The authors received no financial support for the research
and/or authorship of this article.
1) Zardo P, Busk H, Kutschka I. Chest tube management: state
of the art. Curr Opin Anaesthesiol 2015;28:45-9.
2) Chen CH, Liu TP, Chang H, Huang TS, Liu HC, Chen CH. A
chest drainage system with a real-time pressure monitoring
device. J Thorac Dis 2015;7:1119-24.
3) Cerfolio RJ, Tummala RP, Holman WL, Zorn GL, Kirklin
JK, McGiffin DC, et al. A prospective algorithm for the
management of air leaks after pulmonary resection. Ann
Thorac Surg 1998;66:1726-31.
4) Moser C, Opitz I, Zhai W, Rousson V, Russi EW, Weder
W, et al. Autologous fibrin sealant reduces the incidence of
prolonged air leak and duration of chest tube drainage after
lung volume reduction surgery: a prospective randomized
blinded study. J Thorac Cardiovasc Surg 2008;136:843-9.
5) Varela G, Jiménez MF, Novoa NM, Aranda JL. Postoperative
chest tube management: measuring air leak using an electronic
device decreases variability in the clinical practice. Eur J
Cardiothorac Surg 2009;35:28-31.
6) Pompili C, Detterbeck F, Papagiannopoulos K, Sihoe A,
Vachlas K, Maxfield MW, et al. Multicenter international
randomized comparison of objective and subjective outcomes
between electronic and traditional chest drainage systems.
Ann Thorac Surg 2014;98:490-6.
7) Baumann MH, Strange C, Heffner JE, Light R, Kirby TJ,
Klein J, et al. Management of spontaneous pneumothorax:
an American College of Chest Physicians Delphi consensus
statement. Chest 2001;119:590-602.
8) Brown SG, Ball EL, Macdonald SP, Wright C, McD Taylor
D. Spontaneous pneumothorax; a multicentre retrospective
analysis of emergency treatment, complications and
outcomes. Intern Med J 2014;44:450-7.
9) Chee CB, Abisheganaden J, Yeo JK, Lee P, Huan PY, Poh
SC, et al. Persistent air-leak in spontaneous pneumothorax--
clinical course and outcome. Respir Med 1998;92:757-61.
10) Tschopp JM, Bintcliffe O, Astoul P, Canalis E, Driesen P,
Janssen J, et al. ERS task force statement: diagnosis and
treatment of primary spontaneous pneumothorax. Eur Respir
J 2015;46:321-35.
11) Rivas de Andrés JJ1, Jiménez López MF, Molins López-
Rodó L, Pérez Trullén A, Torres Lanzas J. Guidelines for the
diagnosis and treatment of spontaneous pneumothorax. Arch
Bronconeumol 2008;44:437-48. [Abstract]
12) Dernevik L. Use pleural drainage optimally! Current systems
are quick and easy to manage. Lakartidningen 1999;96:5227-30. [Abstract]
13) Anegg U, Lindenmann J, Matzi V, Mujkic D, Maier A,
Fritz L, et al. AIRFIX: the first digital postoperative
chest tube airflowmetry--a novel method to quantify air
leakage after lung resection. Eur J Cardiothorac Surg
2006;29:867-72.
14) Pompili C, Brunelli A, Salati M, Refai M, Sabbatini A.
Impact of the learning curve in the use of a novel electronic
chest drainage system after pulmonary lobectomy: a casematched
analysis on the duration of chest tube usage. Interact
Cardiovasc Thorac Surg 2011;13:490-3.
15) Filosso PL, Ruffini E, Solidoro P, Molinatti M, Bruna MC,
Oliaro A. Digital air leak monitoring after lobectomy for
primary lung cancer in patients with moderate COPD:
can a fast-tracking algorithm reduce postoperative costs
and complications? J Cardiovasc Surg (Torino) 2010;
51:429-33.
16) Brunelli A, Salati M, Refai M, Di Nunzio L, Xiumé F,
Sabbatini A. Evaluation of a new chest tube removal
protocol using digital air leak monitoring after lobectomy:
a prospective randomised trial. Eur J Cardiothorac Surg
2010;37:56-60.
17) Gilbert S, McGuire AL, Maghera S, Sundaresan SR, Seely
AJ, Maziak DE, et al. Randomized trial of digital versus
analog pleural drainage in patients with or without a
pulmonary air leak after lung resection. J Thorac Cardiovasc
Surg 2015;150:1243-9.
18) Chiaramonte LT, Prabhu SL. Comparative evaluation of five
peak flow devices. J Allergy Clin Immunol 1982;69:509-15.
19) Miller MR, Ouanjer PH. Peak flow meters: a problem of
scale. BMJ 1994;308:548-9.
20) Cruz AA. Peak expiratory flow. It"s better to measure! J Bras
Pneumol 2006;32:4-6.